Related Experiment Video

Updated: Jul 13, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action

Guo-Qing Tang1, Yalan Tang1, Ketki Dhamnaskar2

  • 1UCB Pharma, Cambridge, MA, United States.

Frontiers in Immunology
|October 11, 2023
PubMed

Abstract:

[This corrects the article DOI: 10.3389/fimmu.2023.1213920.].

Keywords:
C5 R885 variantsC5 cleavageC5b6MAC formationRBC hemolysiscomplement activationmacrocyclic peptide inhibitorpermeability

More Related Videos

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

7.9K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.5K

Related Experiment Videos

Last Updated: Jul 13, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

7.9K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.5K

Related Concept Videos

Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

481
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
481

Articles linked to this work by shared authors, journal, and citation graph.

Paeonol induces osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells and inhibits adipocyte differentiation.

Tissue & cell·2026

SolenopsisDetector: development of an automatic detection system for fire ants using computer vision and deep learning.

Journal of economic entomology·2026

Nomogram model for predicting spontaneous preterm birth in twin pregnancies: a case-control study.

BMC pregnancy and childbirth·2026

DARibo-Q: RNA Allosteric Transduction for Fluorescence Imaging of Dopamine Modulation in Living Systems.

Analytical chemistry·2026

The clinical and molecular landscape of thalamic glioma.

Neuro-oncology·2026

Recurrent lung cancer with multi-organ metastases showing remarkable regression after two weeks of targeted therapy: a case report.

Journal of cardiothoracic surgery·2026

Transcriptome-based profiling of programmed cell death signatures identifies two osteoarthritis subtypes and the hub gene DNM1L.

Frontiers in immunology·2026

m6A modification in immune-cell inflammatory fate: from RNA fate regulation to therapeutic translation in inflammatory diseases.

Frontiers in immunology·2026

Immune microenvironment of infantile hemangioma: cellular dynamics, molecular networks, and emerging immunomodulatory strategies.

Frontiers in immunology·2026

Neuroimmune regulation of visceral pain: roles of microglia, purinergic signaling, and neuroinflammation.

Frontiers in immunology·2026

Case Report: Post-mortem analysis of long-term inflammation after mild COVID-19.

Frontiers in immunology·2026

Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity.

Frontiers in immunology·2026

Novel tryptamine derivatives incorporating aromatic aldehyde and amide moieties: design, synthesis, and antifungal activity.

Pest management science·2026

The Endocannabinoid System is No Longer the Limiting Factor: Why Policy and Stigma Continue to Delay Cannabinoid-Based Medicine.

Clinical therapeutics·2026

MDMA administration reduces ethanol drinking and is associated with altered nociceptin and dynorphin system gene expression in alcohol-preferring rats.

Neuropharmacology·2026

Mechanisms of NMDA receptor inhibition by fluoroethylnormemantine - comparison with memantine.

European journal of pharmacology·2026

Schisandrol A in Fufang Muniziqi Granules suppresses the abnormal expression of MHC-II in renal tubular epithelial cells to treat lupus nephritis through disrupting the interaction between STUB1 and PPARγ.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Molecular basis for state-dependent drug block of Kv11.1 (human ether-à-go-go-related gene) potassium channels.

Molecular pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us